EE16 Budget Impact Analysis of the Introduction of Dexcom ONE for the Treatment of Patients With T2 Diabetes on an Intensive Insulin Schedule From the Perspective of the Italian Healthcare Payer

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.289
https://www.valueinhealthjournal.com/article/S1098-3015(23)03419-8/fulltext
Section Title :
Section Order : 12181
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03419-8&doi=10.1016/j.jval.2023.09.289
HEOR Topics :
Tags :
Regions :